Cellular and Organismal Toxicity of the Anti-Cancer Small Molecule, Tolfenamic Acid: a Pre-Clinical Evaluation

Publisher： Karger

E-ISSN： 1421-9778|32|3|675-686

ISSN： 1015-8987

Source： Cellular Physiology and Biochemistry, Vol.32, Iss.3, 2013-09, pp. : 675-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Augmenting Anti-Cancer Natural Products with a Small Molecule Adjuvant

By Wahome Paul G.   Beauchesne Kevin R.   Pedone Anna C.   Cavanagh John   Melander Christian   Zimba Paul   Moeller Peter D. R.  

Marine Drugs, Vol. 13, Iss. 1, 2014-12 ,pp. : 65-75

MDPI

Access to resources Recommend Favorite

Marine-Sourced Anti-Cancer and Cancer Pain Control Agents in Clinical and Late Preclinical Development †

By Newman David J.   Cragg Gordon M.  

Marine Drugs, Vol. 12, Iss. 1, 2014-01 ,pp. : 255-278

MDPI

Access to resources Recommend Favorite

A methodology for the pre-clinical evaluation of patellar implants

By Kersh Mariana E.  

International Journal of Experimental and Computational Biomechanics, Vol. 1, Iss. 2, 2009-11 ,pp. : 129-145

Inderscience Publishers

Access to resources Recommend Favorite

Small Molecule Inhibitors of Acid Sphingomyelinase

By  

Cellular Physiology and Biochemistry, Vol. 26, Iss. 1, 2010-05 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

Anti-Cancer Effect of Lambertianic Acid by Inhibiting the AR in LNCaP Cells

By Lee Myoung-Sun   Lee Seon-Ok   Kim Sung-Hoon   Lee Eun-Ok   Lee Hyo-Jeong  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1066-1066

MDPI

Access to resources Recommend Favorite